SCHEMBL217495

SCHEMBL217495

CCCCN1C=NCCC1

nearest known ligand 0.36

Predicted protein targets (top 5)

geneUniProtsupporting neighboursconfidence
CYP1A2 P05177 1/20 0.36
CYP2D6 P10635 1/20 0.36
TSHR P16473 1/20 0.35
HTT P42858 1/20 0.35
ALDH1A1 P00352 1/20 0.31

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL9819152 0.92 ALDH1A1 (0.38) CYP1A2CYP2D6ALDH1A1
SCHEMBL11120717 0.92 ALDH1A1 (0.38) CYP1A2CYP2D6ALDH1A1
SCHEMBL6574015 0.88
SCHEMBL15069744 0.88
SCHEMBL8206512 0.86 CYP1A2 (0.30) CYP1A2CYP2D6
Hydrochloric Acid SCHEMBL29989378 0.86 GNAI3 (0.31) CYP1A2CYP2D6
SCHEMBL168017 0.82 GNAI3 (0.34) CYP1A2CYP2D6ALDH1A1
SCHEMBL9814327 0.80 GNAI3 (0.37) CYP1A2CYP2D6ALDH1A1
Hydrochloric Acid SCHEMBL2904064 0.80 GNAI3 (0.37) CYP1A2CYP2D6ALDH1A1
SCHEMBL11652283 0.80 GNAI3 (0.37) CYP1A2CYP2D6ALDH1A1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 62 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-10570243-B2 Non-tin catalyst for curing alkoxysilyl-containing polymer MOMENTIVE PERFORMANCE MATERIALS INC. (US) 2020-02-25 US claimed
CN-109937225-A For solidifying the non-tin catalyst of the polymer containing alkoxysilyl 莫门蒂夫性能材料股份有限公司 2019-06-25 CN claimed
US-20180072837-A1 NON-TIN CATALYST FOR CURING ALKOXYSILYL-CONTAINING POLYMER MOMENTIVE PERFORMANCE MATERIALS INC. 2018-03-15 US claimed
WO-2026105516-A1 METHOD FOR FORMING MULTILAYER COATING FILM 日本ペイント・オートモーティブコーティングス株式会社 2026-05-21 WO disclosed
WO-2026105512-A1 CLEAR COATING COMPOSITION 日本ペイント・オートモーティブコーティングス株式会社 2026-05-21 WO disclosed
US-20250236755-A1 COATING COMPOSITION AND METHOD FOR FORMING COATING FILM KANSAI PAINT CO., LTD. (JP) 2025-07-24 US disclosed
EP-4481009-A1 COATING COMPOSITION AND METHOD FOR FORMING COATING FILM Kansai Paint Co., Ltd. (JP) 2024-12-25 EP disclosed
CN-118829697-A Coating composition and coating film forming method 关西涂料株式会社 2024-10-22 CN disclosed
WO-2023157942-A1 COATING COMPOSITION AND METHOD FOR FORMING COATING FILM 関西ペイント株式会社 2023-08-24 WO disclosed
WO-2022129138-A1 NON-IONIC HYDROPHILIZED POLYISOCYANATES, CATALYSIS WITH ZINC COMPLEXES COVESTRO DEUTSCHLAND AG (DE) 2022-06-23 WO disclosed
EP-4015547-A1 NONIONICALLY HYDROPHILICIZED POLYISOCYANATES, CATALYSIS WITH ZINC COMPLEXES Covestro Deutschland AG (DE) 2022-06-22 EP disclosed
CN-103842095-A Method for forming coating film and coated article KANSAI PAINT CO LTD 2014-06-04 CN disclosed
US-20140056821-A1 NANOPARTICULATE COMPOSITIONS FOR DIAGNOSTIC IMAGING GENERAL ELECTRIC COMPANY (US) 2014-02-27 US disclosed
US-8088846-B2 Organometallic compositions and coating compositions KING INDUSTRIES, INC. (US) 2012-01-03 US disclosed
US-7485729-B2 Complexes of zinc with substituted amidines and guanidines and aliphatic carboxylates, e.g., Zn(1-methylimidazole)2(acetate)2 and Zn(tetramethylguanidine)2(formate)2; useful as catalysts for deblocking blocked isocyanates and in the production of urethanes and polyurethanes KING INDUSTRIES, INC. (US) 2009-02-03 US disclosed
US-20090011124-A1 Complexes of zinc with substituted amidines and guanidines and aliphatic carboxylates, e.g., Zn(1-methylimidazole)2(acetate)2 and Zn(1-methylimidazole)2(2-ethylhexanoate)2; useful as catalysts for deblocking blocked isocyanates and in the production of urethanes and polyurethanes HSIEH BING 2009-01-08 US disclosed
US-20060247341-A1 Complexes of zinc with substituted amidines and guanidines and aliphatic carboxylates, e.g., Zn(1-methylimidazole)2(acetate)2 and Zn(tetramethylguanidine)2(formate)2; useful as catalysts for deblocking blocked isocyanates and in the production of urethanes and polyurethanes KING INDUSTRIES, INC. 2006-11-02 US disclosed
US-20060036007-A1 Organometallic compositions and coating compositions KING INDUSTRIES, INC. (US) 2006-02-16 US disclosed
EP-0069295-B1 PROCESS FOR THE MANUFACTURE OF POSSIBLY CELLULAR POLYURETHANE OR POLYURETHANE-POLYUREA MOULDED ARTICLES BASF Aktiengesellschaft (DE) 1986-05-21 EP disclosed
US-4469653-A AS POLYMERIZATION CATALYSTS BASF AKTIENGESELLSCHAFT (DE) 1984-09-04 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20140056821-A1 NANOPARTICULATE COMPOSITIONS FOR DIAGNOSTIC IMAGING C1S, C1R, C3AR1 CYP1A2 4365/4885CYP2D6 4020/4885TSHR 978/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.